The program, which can also be accessed through video broadcast, once again includes a section on biosimilars. On this occasion, Dr. Antoni Gilabert, doctor of pharmacy and director of innovation at the Consorci Català de la Salut, participates in it, explaining how biosimilars are a support tool for the Administration, thus contributing to improving the accessibility of patients to biological therapies and the sustainability of the SNS.

READ MORE